Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biomerica Inc BMRA

Healthcare Medical Devices
Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in... see more

Recent & Breaking News (NDAQ:BMRA)

Mid-Day Market Update: SUPERVALU Drops After Q3 Results; AMERI Holdings Shares Climb

Benzinga.com  January 10, 2018

Mid-Morning Market Update: Markets Open Lower; Lennar Earnings Miss Expectations

Benzinga.com  January 10, 2018

China Food and Drug Administration (CFDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer

GlobeNewswire January 10, 2018

Biomerica Signs Agreements with Beth Israel Deaconess & University of Michigan to Initiate Clinical Study for First of a Kind, Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy (DGT)

GlobeNewswire January 8, 2018

Biomerica Announces Enrollment of First Patient for H. Pylori Clinical Studies at the University of Southern California

Accesswire November 20, 2017

Biomerica Extends Exclusive License Agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019

GlobeNewswire November 7, 2017

Biomerica Reports 1st Quarter Fiscal 2018 Financials

GlobeNewswire October 17, 2017

Biomerica Commences Clinical Studies for New Gastroenterology H. Pylori Test

GlobeNewswire September 12, 2017

Biomerica Announces Fiscal Year End 2017 Financial Results; Sales Up 12.7% for the year

GlobeNewswire August 30, 2017

Biomerica Announces Point of Care Product Distribution Agreement with a Multinational Pharmaceutical Company

GlobeNewswire August 16, 2017

Biomerica to present at the 18th Annual B. Riley & Co. investor conference on May 24, 2017

Marketwired May 23, 2017

Biomerica Announces Third Quarter Financial Results, Sales up 13.9% for Nine Months

Marketwired April 17, 2017

Biomerica to present at the 29th Annual ROTH conference on March 13, 2017

Marketwired March 9, 2017

15 Biggest Mid-Day Gainers For Monday

Benzinga.com  December 5, 2016

Biomerica to Present at the 9th Annual LD Micro Main Event

Accesswire November 30, 2016

Exclusive: Newly-Listed Biomerica's CEO Talks IBS, Tech And Patient Care

Benzinga.com  September 6, 2016

Biomerica Announces Third Quarter Financial Results, Sales up 10% for Nine Months

Marketwired April 15, 2016

All Board Members of Biomerica to Purchase Biomerica Common Stock Shares in the Open Market

Marketwired April 7, 2016

Biomerica Announced That Its International Patent Application for IBS Was Reviewed by the ISA and All Claims Have Been Deemed Novel and Non-Obvious

Marketwired March 14, 2016

Biomerica to Present at the ROTH Conference on March 16, 2016

Marketwired March 10, 2016